We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01651611
First Posted: July 27, 2012
Last Update Posted: August 29, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Harvard School of Public Health
The Miriam Hospital
Boston Housing Authority
Information provided by (Responsible Party):
Boston University
  Purpose
The purpose of this study is to determine whether public housing residents trained in Tobacco Cessation and Motivational Interviewing Techniques to become Tobacco Treatment Advocates(TTA) will be effective in increasing the quit rate of smokers in Boston Public Housing. The investigators hypothesize that smokers that receive multiple TTA visits will be more likely to (1) use smoking cessation resources and (2) quit compared to smokers who receive a single visit.

Condition Intervention
Tobacco Cessation Behavioral: Motivational interviewing Behavioral: Smoking cessation counseling Behavioral: Navigation to smoking cessation resources Behavioral: Social support

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Health Advocates as a Vehicle to Improve Treatment for Smokers in Public Housing

Resource links provided by NLM:


Further study details as provided by Boston University:

Primary Outcome Measures:
  • Point prevalence smoking abstinence [ Time Frame: 7 months ]
    7 and 30-day abstinence from smoking by self-report with verification by carbon monoxide breath test


Secondary Outcome Measures:
  • Utilization of smoking cessation resources [ Time Frame: 7 months ]
    Use of SQL, smoking cessation programs at health clinics or hospitals, physician counseling


Other Outcome Measures:
  • Medication use [ Time Frame: 3 months, 7 months, 12 months ]
    Use of nicotine replacement therapy and/or other smoking cessation medications


Enrollment: 330
Study Start Date: September 2011
Study Completion Date: September 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Extensive TTA interaction
Persons interested in quitting smoking will receive multiple in-person visits from a peer Tobacco Treatment Advocate (TTA) who will provide motivational interviewing, basic smoking cessation counseling assistance, navigation to smoking cessation resources, and social support.
Behavioral: Motivational interviewing
The TTA will use motivational interviewing (MI) techniques to assess the participant's motivation and readiness to quit, suggest plans, and assist the participant in selecting a method of treatment.
Behavioral: Smoking cessation counseling
The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.
Behavioral: Navigation to smoking cessation resources
The TTA will assist participants in obtaining NRT and getting connected to smoking cessation counseling services, such as the Smokers' Quitline and clinic-based programs.
Behavioral: Social support
Meetings with the TTA will be a source of social support for the participant as they attempt to quit or stay quit.
Active Comparator: Minimal TTA interaction
Persons interested in quitting smoking will receive a single in-person visit from a peer Tobacco Treatment Advocate (TTA) who will provide basic smoking cessation counseling assistance.
Behavioral: Smoking cessation counseling
The TTA will provide information to the participant regarding evidence-based treatments for smoking cessation, including counseling and nicotine replacement therapy (NRT); assist in a quit plan; and discuss issues such as obtaining social support, staying in treatment, and dealing with lapses.

Detailed Description:
The study is a group-randomized trial in which 10 pubic housing developments (PHDs) are randomized to the experimental condition and 10 to the control condition. All smokers who enroll in the study at a particular PHD receive the same intervention. Smokers at control sites receive written materials that offer strategies for quitting and information about availability of treatment programs, as well as a one-time meeting with a Tobacco Treatment Advocate (TTA). The intervention group receives the same written materials but also has much more extensive interactions with a TTA. TTAs provide peer counseling (Peer Counseling is defined as: performance of limited counselor functions, under counselor supervision, by person of similar age,gender, race, ethnicity and/or SES of the counselee) to smokers during in- person Motivational Enhancement meetings (target range 7-9) as well as additional in person and phone contacts, as needed for each participant, over a 6-month period. TTAs receive intensive training in motivational interviewing and smoking cessation counseling deliver the intervention components (counseling activities and provision of environmental supports) in addition to encouraging utilization of smoking cessation treatment programs such as the Smokers' QuitLine (SQL) and clinic-based programs. In order to avoid the potential for contamination due to TTAs interacting with participants at both intervention and control sites, meetings with participants at control sites are conducted by special Control TTAs. Data are collected from study participants at baseline, 3 months, 7 months and 12 months, and also from the SQL and clinics.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 79 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Current smoker, defined as having smoked in last 100days
  • Housing Sites: Sites are eligible for the study if they have 50+ smokers determined by synthetic estimates based on citywide survey data.
  • Age 18-79
  • Current everyday or someday smokers
  • Planning to quit smoking in 30 days or thinking about quitting in next 6 months,
  • Have smoked 100 cigarettes in lifetime
  • Speak English or Spanish
  • Plan to live in Public Housing for next 12 months
  • Able and willing to provide consent

Exclusion Criteria:

  • Smokers less than 18 years of age at time of consent.
  • Unable to communicate orally in English or Spanish.
  • Currently using pharmacological treatment for smoking cessation
  • Currently working with the Smokers Quitline or other Community Health Center based cessation program
  • Cognitive/ psychiatric conditions that would interfere with ability to understand and participate in the study
  • Have been abstinent for 7 or more days.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01651611


Locations
United States, Massachusetts
Boston University School of Public Health
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Boston University
Harvard School of Public Health
The Miriam Hospital
Boston Housing Authority
Investigators
Principal Investigator: Daniel R Brooks, DSc Boston University
  More Information

Responsible Party: Boston University
ClinicalTrials.gov Identifier: NCT01651611     History of Changes
Other Study ID Numbers: H-28386
1R01CA141587-03 ( U.S. NIH Grant/Contract )
First Submitted: July 24, 2012
First Posted: July 27, 2012
Last Update Posted: August 29, 2016
Last Verified: January 2015
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Boston University:
Tobacco Cessation
Public Housing
Community Health Workers
Motivational Interviewing
Patient centered
Low-income
Tobacco Treatment Advocates
Social Epidemiology
Smoking cessation predictors
Behavioral Intervention
Non-pharmacologic